Serkan Ozakbas
Dokuz Eylül Üniversitesi
H-index: 28
Asia-Turkey
Top articles of Serkan Ozakbas
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60 | Journal of Neurology, Neurosurgery & Psychiatry | Yi Chao Foong Daniel Merlo Melissa Gresle Katherine Buzzard Michael Zhong | 2024/3/7 |
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries | The Lancet Child & Adolescent Health | Sifat Sharmin Izanne Roos Charles B Malpas Pietro Iaffaldano Marta Simone | 2024/5/1 |
Investigation of the Relationship Between Coping With the Disease and Affecting Cognitive, Physical, and Psychosocial Factors in People with Multiple Sclerosis | Archives of Clinical Neuropsychology | Ozge Sagici Asiye Tuba Ozdogar Taha Aslan Serkan Ozakbas | 2024/1/11 |
COVID-19 vaccine response in Neuromyelitis Optica Spectrum Disorder | Clinical Neurology and Neurosurgery | Cavid Baba Ergi Kaya Sinem Ozcelik Asiye Tuba Ozdogar Ulvi Samadzade | 2024/3/1 |
Feasibility of exergaming for upper extremity rehabilitation in people with multiple sclerosis: prospective clinical trial | Acta Neurologica Belgica | AT Ozdogar M Emec E Kaya H Karakas S Dastan | 2024/4/26 |
Sedentary behaviour and related factors in people with multiple sclerosis | Multiple Sclerosis and Related Disorders | Özge Ertekin Tuğçe Kara Zuhal Abasıyanık Turhan Kahraman Serkan Özakbaş | 2024/1/1 |
Cognition As a Parameter in Monitoring The Effect of Multiple Sclerosis Relapse Treatment: A Prospective Controlled Study | Clinical Neurology and Neurosurgery | B Piri Cinar C Baba S Demir C Uzunkopru M Seferoglu | 2024/2/16 |
Comparative effectiveness of natalizumab, fingolimod, and injectable therapies in pediatric-onset multiple sclerosis: A registry-based study | Neurology | Tim Spelman Gabrielle Simoneau Robert Hyde Robert Kuhelj Raed Alroughani | 2024/4/9 |
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies | Journal of neurology | Ying Li Alice Saul Bruce Taylor Anne-Louise Ponsonby Steve Simpson-Yap | 2024/1 |
What might the COVID‐19 pandemic in regard to people with neuromyelitis optica spectrum disorder teach us regarding the future? | Clinical and Experimental Neuroimmunology | Cavid Baba Ipek Yavas Ulvi Samadzade Asiye Tuba Ozdogar Serkan Ozakbas | 2024/2 |
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey | Journal of Neurology | Muammer Çelik Cavid Baba Çağlar Irmak Serkan Özakbaş Vildan Avkan-Oğuz | 2024/4/5 |
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry | Journal of Neurology, Neurosurgery & Psychiatry | Alessio Signori Marta Ponzano Tomas Kalincik Serkan Ozakbas Dana Horakova | 2024/1/19 |
Discriminative ability of the original and short form of the Activities-specific Balance Confidence scale and its individual items for falls in people with multiple sclerosis | Acta neurologica Belgica | Zuhal Abasıyanık Turhan Kahraman Cavid Baba Özge Sağıcı Özge Ertekin | 2024/3/14 |
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom | Journal of medical economics | T Spelman WL Herring C Acosta R Hyde VG Jokubaitis | 2024/12/31 |
Predictors of relapse severity in multiple sclerosis | Acta Neurologica Belgica | Cavid Baba Zuhal Abasiyanik Yasemin Simsek Asiye Tuba Ozdogar Ozge Sagici | 2024/1/18 |
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis | European Journal of Neurology | Ibrahima Diouf Charles B Malpas Sifat Sharmin Izanne Roos Dana Horakova | 2023/4 |
Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis | JAMA neurology | Izanne Roos Stella Hughes Gavin McDonnell Charles B Malpas Sifat Sharmin | 2023/8/1 |
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis | Multiple Sclerosis Journal | Cyrus Daruwalla Vahid Shaygannejad Serkan Ozakbas Eva Kubala Havrdova Dana Horakova | 2023/6 |
Vascular comorbidities are associated with increased relapse rates in relapsing-remitting MS | Yingtong Li Talal Al-Harbi Raed Alroughani Ayse Altintas Maria Pia Amato | 2023/10/1 | |
A Pilot Study on Sex Hormones and Cognition in Men with Multiple Sclerosis | Journal of Urological Surgery | Bilge Piri Çınar Mustafa Açıkgöz Önder Çinar Ulufer Çelebi Sibel Çekiç | 2023/12/1 |
Co-Authors
